HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

V Ramesh Selected Research

Lepromatous Leprosy

1/2013CD4+ Th17 cells discriminate clinical types and constitute a third subset of non Th1, Non Th2 T cells in human leprosy.
2/2012Lsr2 peptides of Mycobacterium leprae show hierarchical responses in lymphoproliferative assays, with selective recognition by patients with anergic lepromatous leprosy.
2/2010Some unusual type 2 reactions in leprosy.
12/2000The effect of antigen presenting cells on the cytokine profiles of stable and reactional lepromatous leprosy patients.
12/2000Dysregulation of IL-4 expression in lepromatous leprosy patients with and without erythema nodosum leprosum.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


V Ramesh Research Topics

Disease

21Visceral Leishmaniasis (Kala Azar)
01/2020 - 03/2001
19Leishmaniasis
01/2020 - 03/2001
12Leprosy (Hansen's Disease)
01/2022 - 05/2000
9Cutaneous Tuberculosis (Scrofuloderma)
10/2022 - 09/2001
9Coronary Artery Disease (Coronary Atherosclerosis)
06/2017 - 01/2003
8Neoplasms (Cancer)
07/2017 - 05/2000
5Lepromatous Leprosy
01/2013 - 12/2000
4Infections
10/2019 - 05/2000
4Tuberculosis (Tuberculoses)
09/2013 - 01/2004
4Tuberous Sclerosis (Bourneville's Disease)
06/2003 - 05/2000
3Inflammation (Inflammations)
01/2022 - 11/2003
3Psoriasis (Pustulosis Palmaris et Plantaris)
01/2020 - 07/2017
3Erythema Nodosum
02/2010 - 12/2000
3Hamartoma
06/2003 - 05/2000
2Atrophy
11/2020 - 02/2006
2Dermatitis
11/2020 - 11/2007
2Hypertension (High Blood Pressure)
01/2020 - 12/2008
2Tuberculoid Leprosy
01/2013 - 12/2000
2Liver Failure
01/2009 - 02/2008
2Seizures (Absence Seizure)
01/2009 - 02/2008
2Lymphoma (Lymphomas)
03/2008 - 03/2006
2Abscess
10/2007 - 05/2000
2Myocardial Infarction
07/2005 - 12/2003
2Sleep Deprivation
01/2002 - 01/2001
2Dystonia musculorum deformans type 1
07/2001 - 05/2000
1Pyogenic Granuloma
11/2021
1Pruritus (Itching)
11/2020
1Scabies (Sarcoptic Mange)
11/2020
1Melanosis (Freckles)
11/2020
1Hypopigmentation (Hypomelanosis)
11/2020
1Gingival Overgrowth
09/2020
1Drug-Related Side Effects and Adverse Reactions
09/2020
1Body Weight (Weight, Body)
01/2020
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020
1Mycetoma
10/2019
1Spinal Muscular Atrophy (Progressive Muscular Atrophy)
09/2019
1Acneiform Eruptions
07/2017
1Premature Aging
07/2017

Drug/Important Bio-Agent (IBA)

10miltefosine (Impavido)IBA
01/2020 - 01/2008
9Proteins (Proteins, Gene)FDA Link
01/2019 - 05/2000
8Pharmaceutical PreparationsIBA
10/2022 - 09/2001
6CytokinesIBA
01/2016 - 12/2000
4DNA (Deoxyribonucleic Acid)IBA
09/2020 - 03/2001
4Interleukin-17 (Interleukin 17)IBA
01/2020 - 01/2013
4N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA
01/2020 - 01/2012
4AntioxidantsIBA
04/2015 - 07/2005
4AntigensIBA
01/2013 - 03/2002
3Adrenal Cortex Hormones (Corticosteroids)IBA
11/2021 - 05/2000
3Biological ProductsIBA
01/2017 - 01/2004
3LipidsIBA
04/2015 - 01/2003
3Interleukin-10 (Interleukin 10)IBA
01/2011 - 12/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2010 - 03/2005
3trans-sodium crocetinate (crocetin)IBA
06/2003 - 05/2000
2Glucose (Dextrose)FDA LinkGeneric
01/2020 - 12/2008
2liposomal amphotericin BFDA Link
01/2020 - 01/2018
2Amphotericin B (Amphotericin)FDA LinkGeneric
10/2019 - 12/2009
2Tuberculin (PPD)IBA
07/2015 - 11/2007
2BilirubinIBA
04/2015 - 07/2005
2Ascorbic Acid (Vitamin C)FDA LinkGeneric
04/2015 - 07/2005
2EnzymesIBA
04/2015 - 03/2002
2Amlodipine (Norvasc)FDA LinkGeneric
05/2013 - 10/2012
2Interleukin-4 (Interleukin 4)IBA
01/2013 - 12/2000
2Peptides (Polypeptides)IBA
02/2012 - 04/2004
2CalciumIBA
01/2011 - 09/2001
2Rifampin (Rifampicin)FDA LinkGeneric
04/2010 - 03/2010
2Valproic Acid (Depakote)FDA LinkGeneric
01/2009 - 02/2008
2Neurofibromin 2 (Merlin)IBA
06/2001 - 01/2001
2Tuberous Sclerosis Complex 2 ProteinIBA
03/2001 - 05/2000
2Tuberous Sclerosis Complex 1 ProteinIBA
03/2001 - 05/2000
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
12/2000 - 12/2000
1interleukin-21 (interleukin 21)IBA
01/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2020
1Hair DyesIBA
11/2020
1Melanins (Melanin)IBA
11/2020
1Stem Cell FactorIBA
11/2020
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
11/2020
1Triamcinolone (Aristocort)FDA Link
11/2020
1Tacrolimus (Prograf)FDA LinkGeneric
11/2020
1Ointments (Pastes)IBA
11/2020
1Phenytoin (Dilantin)FDA LinkGeneric
09/2020
1Anticonvulsants (Antiepileptic Drugs)IBA
09/2020
1Cytochrome P-450 CYP2C9IBA
09/2020
1Triglycerides (Triacylglycerol)IBA
01/2020
1HDL CholesterolIBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
1Caspofungin (Cancidas)FDA Link
10/2019
1Itraconazole (Sporanox)FDA LinkGeneric
10/2019
1Fluconazole (Zonal)FDA LinkGeneric
10/2019
1Ketoconazole (Nizoral)FDA LinkGeneric
10/2019
1posaconazoleFDA Link
10/2019
1Voriconazole (Vfend)FDA LinkGeneric
10/2019
1Mitochondrial DNA (mtDNA)IBA
09/2019
1HydrocarbonsIBA
07/2017
1SmokeIBA
07/2017

Therapy/Procedure

21Therapeutics
10/2022 - 05/2000
4Drug Therapy (Chemotherapy)
05/2014 - 02/2010
2Injections
01/2020 - 03/2010
2Aftercare (After-Treatment)
02/2010 - 12/2009
1Drug Substitution
09/2020
1Treatment Delay
11/2018